Lupin gets green signal for 10 drugs in Japan
April 23rd, 2008 - 11:26 pm ICT by admin - Send to a friend:
Mumbai, April 23 (IANS) Pharma major Lupin Ltd announced Wednesday that its Japanese subsidiary Kyowa Pharmaceutical Industry Ltd (Kyowa) has received approvals for 10 products from Japan’s Ministry of Health and Labour Welfare (MHLW). The company said that it expects to launch these products by July 2008.
According to an official communiqu
Related Stories
- Ranbaxy gets Japanese nod for blood pressure drug - April 8, 2008
- Lupin acquires South African pharma company - September 18, 2008
- US approves Lupin’s anti-depressant drug - June 17, 2008
- Lupin acquires German pharma company - July 30, 2008
- Lupin enters into alliance with US firm - August 19, 2008
- Lupin receives US approval for another drug - July 31, 2008
- Lupin acquires minority stake in Australian drug firm - August 21, 2008
- Railways gives green signal to Arshiya for freight trains - April 10, 2008
- Glenmark launches skin drugs in the US - March 17, 2008
- Bafna Pharmaceuticals to float IPO on May 27 - May 22, 2008
- Bajaj Allianz targets Rs.1.2 bn premium from health cover - July 11, 2008
- Otsuka Chemical launches new pharma plant in Rajasthan - May 17, 2008
- Bhutan seeks India’s help to set up medical college - July 15, 2008
- Food safety body wants Chinese dairy products banned - September 23, 2008
- Radha Madhav pharma packaging unit online - April 22, 2008
Categories
Tags
- amlodipine
- drugs
- generic player
- ims data
- industry ltd
- intercontinental marketing
- japan
- japanese subsidiary
- kyowa pharmaceutical
- labour welfare
- market share
- marketing services
- medicines
- ministry of health
- mumbai
- pharmaceutical industry
- pharmaceutical market
- segment
Posted in Health Science, |
